Merck buying Cubist Pharmaceuticals for $8.4B

NEW YORK (AP) — Merck is buying Cubist Pharmaceuticals for $8.4 billion, illustrating a new emphasis on combating so-called "superbugs" that are drawing dire warnings from global health organizations.



Merck buying Cubist Pharmaceuticals for $8.4B



source U.S. News - News http://ift.tt/1qj6uu7